The cardiac implant devices market is projected to grow at a CAGR of 4.30% to reach US$40.300 billion by 2024, from US$31.300 billion in 2018. Cardiac implant devices are implants which are embedded in the human body through surgical procedures to restore the normal functioning of the heart. The prevalence of cardiovascular diseases worldwide is driving the growth of global cardiac implant devices. Other driving factors include growing medical tourism in emerging economies, the growing adoption of minimally invasive surgeries and rising geriatric population. The increase in healthcare spending is further promoting the market growth accompanied by the increasing infrastructure investments. Region wise, the United States from the North American region is expected to hold a significant market share followed by the Asia Pacific region as the fastest growing market.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the cardiac implant devices value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the cardiac implant devices market.
Major industry players profiled as part of the report are Medtronic, Abbott, Boston Scientific Corporation or its affiliates, Edwards Lifesciences Corporation, and Terumo Europe NV and its Affiliates among others.
The cardiac implant devices market has been analyzed through following segments:
By Product Type
Implantable Closure Devices
Implantable Cardioverter Defibrillator (ICD)
Left Atrial Appendage (LAA) Closure Device
Prosthetic Heart Valves
Insertable Cardiac Monitor (ICM)
Implantable Heart Pump
Total Artificial Heart
Middle East and Africa
Key insights offered
What will be the cardiac implant devices market size from 2018 to 2024?
How are the major drivers and restraints affecting the cardiac implant devices market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.